Development and Preclinical Evaluation of [⁶⁸Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression

Immunotherapy targeting the programmed death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) pathway has shown remarkable efficacy against various cancers, but the overall response rate (ORR) is still low. PD-L1 expression in tumors may predict treatment response to immunotherapy. Indeed, on...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yong Huang, Chengze Li, Zhongjing Li, Qiong Wang, Size Huang, Qi Liu, Ying Liang
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-10-01
Series:	Pharmaceuticals
Assuntos:	[<sup>68</sup>Ga]BMSH immunotherapy programmed death-ligand 1 positron emission-computed tomography
Acceso en liña:	https://www.mdpi.com/1424-8247/16/10/1487
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!